Kenneth J. Eilertsen

Infigen, Inc. provides biotechnology research services. It develops xenotransplantation technology to allow animal organs to be transplanted into humans. The company's products are used in various therapeutic applications including surgery, trauma, cancer therapy, urinary & fecal incontinence, and cosmetic reconstruction. The firm was founded in 1997 and is headquartered in DeForest, WI

Pennington Biomedical Research Center is a medical research center affiliated with Louisiana State University. The center is located in state-of-the-art research facilities on a 222-acre campus. The non-profit company is based in Baton Rouge, LA. The center conducts basic, clinical, and population research to understand the triggers of obesity, diabetes, cardiovascular disease, cancer, and dementia. With over 500 employees, the research enterprise includes a network of 40 clinics, research laboratories, and 13 highly specialized core service facilities.

NuPotential, Inc. engages in the discovery and development of novel drugs that modulate epigenetic targets and their processes for the treatment of cancer. It specializes in producing de-differentiated cell lines suitable for re-differentiation into multiple lineages and somatic cell nuclear transfers. The company was founded by Kenneth J. Eilertsen and Charles Oehler in 2007 and is headquartered in Baton Rouge, LA.